Evidence map›Paper›PMID 42903557›Full record

ReviewFrontiers in immunology2026

Macrophages in spatial context: cellular niches in lung disease.

Akira Yamamoto, Nobuharu Fujii, Yoshinobu Maeda

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Akira YamamotoDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Nobuharu FujiiDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Yoshinobu MaedaDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in spatial omics are shifting the study of lung macrophages from the characterization of isolated transcriptional states toward an understanding of their function in the context of cellular origin, anatomical location, neighboring cells, and tissue architecture. Here, we distinguish the macrophage niche in the strict sense-the local microenvironment that sustains tissue-resident macrophage survival and identity-from the broader cellular niche, in which macrophages are spatially organized with multiple interacting cell populations, and integrate recent insights into lung repair and chronic remodeling. Following injury, remodeling of the resident macrophage compartment, recruitment of monocyte-derived macrophages, and the emergence of regenerative epithelial intermediates and stromal responses generate transient multicellular environments that normally resolve as tissue homeostasis is restored. Spatial analyses, however, indicate that in at least some lung diseases, these repair-associated states fail to resolve and instead become organized into pathological cellular niches characterized by recurrent proximity among aberrant epithelial cells, inflammatory and profibrotic macrophages, activated stromal cells, and extracellular matrix. We further propose a spatial framework in which shared immune-epithelial-stromal interactions can give rise to distinct fibrotic architectures depending on whether they are anchored within alveolar-interstitial regions or around small airways. Finally, we discuss how pathological cellular niches identified by spatial approaches can be functionally validated and translated into therapeutically actionable intercellular circuits.

Indexed as

Cellular MicroenvironmentLung DiseasesMacrophagesMacrophages, AlveolarAnimalsHumansLungbronchiolitis obliteranslung macrophagesmacrophage nichemonocyte-derived macrophagespathological cellular nichepulmonary fibrosisspatial omicstissue repair

Identifiers

PMID42903557
PMCPMC13681187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.